US$ 28.46
when was the first glp 1 agonist approved GLP-1 Receptor Market Size Another milestone in the evolution
Description
Method The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched from the establishment of the database to December 24, 2022

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Multiple studies highlight its potential applications in prevention

95% CI 0.35, 3.14)
